BioCentury
ARTICLE | Clinical News

Allos preclinical data

February 20, 2006 8:00 AM UTC

Data from various in vitro and in vivo studies showed that pralatrexate plus gemcitabine was superior to the combination of methotrexate/cytarabine and was more potent in inducing apoptosis. In mice, ...